Riley Jennifer
SEC CIK 2047607 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AVTX | Avalo Therapeutics, Inc. | Chief Strategy Off | 37.0K | — | $52.0K | 4 | 2025-12-10 | 2026-08-11 |
Most active insiders at AVTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sullivan Christopher Ryan | CFO | — | $3.72M |
| 2 | Doyle Mittie | Chief Medical Off | — | $2.98M |
| 3 | VARKI PAUL | CLO | — | $1.51M |
| 4 | Goldman Jonathan | Dir | — | $163.0K |
| 5 | Chan Mitchell | Dir | — | $72.5K |
| 6 | Riley Jennifer | Chief Strategy Off | — | $52.0K |
| 7 | Truex Samantha | Dir | — | — |
| 8 | KANTOFF AARON | Dir | — | — |
| 9 | NEIL GARRY ARTHUR | CEO, Dir | — | — |
| 10 | KAPLAN GILLA | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-12 16:10 | 2026-08-11 | AVTX | Avalo Therapeutics, Inc. | Riley Jennifer | Chief Strategy Off | S - Sale | $19.59 | -2,655 | 37.0K | -7% | -$52.0K | |
| 2026-06-12 16:43 | 2026-06-10 | AVTX | Avalo Therapeutics, Inc. | Riley Jennifer | Chief Strategy Off | F - Tax | $13.10 | -588 | 39.7K | -1% | -$7,703 | |
| 2026-05-26 16:10 | 2026-05-21 | AVTX | Avalo Therapeutics, Inc. | Riley Jennifer | Chief Strategy Off | A - Grant | $0.00 | +34.2K | 36.9K | +1,288% | $0 | |
| 2025-12-12 | 2025-12-10 | AVTX | Avalo Therapeutics, Inc. | Riley Jennifer | Chief Strategy Off | F - Tax | $4.10 | -637 | 2,655 | -19% | -$2,612 |
Purchase Sale Sale after option exercise All abbreviations